BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8438499)

  • 1. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice.
    Hori J; Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1996 Jun; 28(3):1990-1. PubMed ID: 8658970
    [No Abstract]   [Full Text] [Related]  

  • 3. CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody.
    Koulmanda M; Mandel TE
    Transplant Proc; 1992 Oct; 24(5):2297-8. PubMed ID: 1413065
    [No Abstract]   [Full Text] [Related]  

  • 4. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention and reversal of renal allograft rejection by monoclonal antibody to CD45RB in the mouse model.
    Zhang Z; Zhong R; Grant D; Garcia B; White M; Stiller C; Lazarovits A
    Transplant Proc; 1995 Feb; 27(1):389. PubMed ID: 7879031
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
    Hamano K; Morris PJ; Wood KJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
    Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences.
    Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH
    Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
    Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
    [No Abstract]   [Full Text] [Related]  

  • 13. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-MHC antigens and their relative resistance to immunosuppression after corneal transplantation.
    Nicholls SM; Bradley BA; Easty DL
    Eye (Lond); 1995; 9 ( Pt 2)():208-14. PubMed ID: 7556719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice.
    Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1995 Apr; 27(2):1899-900. PubMed ID: 7725542
    [No Abstract]   [Full Text] [Related]  

  • 18. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y; Boisgerault F; Benichou G; Dana MR
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.